Patrick McIlvenny
Comptroller/Controller/Auditor chez HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Postes actifs de Patrick McIlvenny
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Comptroller/Controller/Auditor | 11/11/2022 | - |
| Corporate Officer/Principal | 05/05/2022 | 11/11/2022 |
Historique de carrière de Patrick McIlvenny
Formation de Patrick McIlvenny
| University of Ulster | Undergraduate Degree |
Statistiques
Internationale
| Irlande | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Bourse
- Insiders
- Patrick McIlvenny
- Expérience
